virologist
benefit
largescal
profil
method
discov
new
hostviru
interact
learn
mechan
pathogenesi
one
techniqu
refer
activitybas
protein
profil
abpp
use
activ
sitedirect
probe
monitor
function
state
enzym
take
account
posttransl
interact
modif
abpp
give
insight
catalyt
activ
enzym
famili
necessarili
correl
protein
abund
abpp
use
investig
sever
virus
interact
host
differenti
enzymat
activ
induc
virus
monitor
use
abpp
review
present
recent
advanc
trend
involv
use
abpp
method
understand
hostviru
interact
identifi
novel
target
diagnost
therapeut
applic
deciph
hostvir
interact
virus
constantli
adapt
transform
host
environ
enabl
replic
propag
part
molecular
interact
host
protein
often
modifi
regular
endogen
function
although
viral
genom
first
complet
sequencedow
rel
small
size
encod
protein
modifi
proteom
host
elucid
studi
reveal
fascin
intricaci
multifunct
enzym
altern
open
read
frame
within
viral
genom
success
sequenc
human
genom
genom
model
host
organ
current
challeng
abl
monitor
effect
viral
infect
host
proteom
uncov
novel
hostviru
interact
discov
perturb
affect
cell
function
viral
propag
diseas
progress
ultim
new
method
develop
obtain
better
understand
mechan
viral
pathogenesi
convent
abundancebas
viral
proteom
similar
microarray
technolog
enabl
global
gene
express
analys
advanc
highthroughput
mass
spectrometri
ms
technolog
revolution
specif
global
protein
analys
coupl
gel
electrophoresi
lcmsm
see
glossari
analysi
tryptic
fragment
deriv
protein
digest
commonli
use
detect
abund
chang
viral
host
proteom
respons
viral
infect
techniqu
unveil
sever
protein
play
import
role
pathogenesi
human
immunodefici
viru
hiv
hepat
c
viru
hcv
sever
acut
respiratori
syndrom
sar
encephalomyocard
viru
simian
viru
overcom
geltogel
variat
differenti
gel
electrophoresi
techniqu
develop
studi
differ
two
proteom
sampl
ie
pathogen
versu
nonpathogen
approach
sampl
label
uniqu
fluoresc
dye
subsequ
detect
gel
differenti
express
samplespecif
protein
readili
detect
analyz
base
distinct
color
spot
appli
studi
hostviru
interact
sever
viral
infect
hiv
dengu
viru
sar
glossari
abppmultidimension
protein
identif
abppmudpit
highthroughput
gelfre
abpp
approach
involv
biotinyl
abp
label
activ
proteom
purif
biotinyl
abplabel
protein
strept
avidin
bead
allow
enrich
identifi
less
abund
protein
target
bioorthogon
function
group
chemic
moieti
unreact
toward
function
group
found
biolog
system
may
undergo
reaction
presenc
specif
molecul
compar
abpp
abpp
applic
compar
two
proteom
analyz
differ
activ
competit
abpp
competit
mode
abpp
specif
inhibitor
identifi
abil
block
access
abp
enzym
activ
site
lcmsm
liquid
chromatographytandem
mass
spectrometri
analyt
techniqu
hydrolyz
protein
fragment
separ
liquid
chromatographi
assess
abund
initi
mass
spectromet
peptid
subsequ
fragment
collis
induc
dissoci
determin
origin
peptid
sequenc
second
mass
spectromet
proteom
entir
set
protein
express
genom
cell
tissu
organ
given
time
biolog
state
stabl
isotop
label
amino
acid
cell
cultur
silac
quantit
proteom
techniqu
use
nonradioact
isotop
label
lcmsm
determin
protein
abund
tandemorthogon
proteolysisabpp
topabpp
abpp
method
enrich
specif
abplabel
peptid
fragment
discard
remain
digest
proteom
use
tobacco
etch
viru
proteolyt
site
abp
elimin
fals
posit
determin
accur
probelabel
activ
site
protein
target
chemic
structur
abp
consist
two
essenti
compon
warhead
reactiv
group
eg
small
molecul
inhibitor
substratebas
scaffold
proteinreact
molecul
coval
target
catalyt
amino
acid
residu
enzym
activ
site
report
tag
fluorophor
biotin
detect
purif
linker
region
flexibl
chain
vari
length
hydrophob
connect
act
spacer
warhead
bulki
fluorophor
tag
b
clickabl
linker
commonli
exploit
coppercatalyz
n
alkyn
cycloaddit
coupl
chemic
inert
alkyn
b
group
abp
n
group
report
tag
click
chemistri
appli
field
abpp
allow
activ
proteom
label
situ
vivo
precis
quantif
differenti
express
protein
difficult
obtain
simpli
examin
gel
altern
gelfre
method
stabl
isotop
label
amino
acid
cell
cultur
silac
use
quantifi
accur
intric
chang
host
protein
caus
viral
infect
specif
silac
util
detect
chang
viral
host
proteom
respons
mani
viral
infect
includ
coronavirus
hiv
influenza
viru
pseudorabi
viru
hcv
despit
signific
find
result
abundancebas
approach
exampl
fail
captur
mani
dynam
chang
posttransl
modif
proteolyt
process
associ
cofactor
regulatori
protein
influenc
activ
enzym
zymogen
applic
activitybas
protein
profil
abpp
studi
hostvir
system
identifi
host
enzym
differenti
regul
viral
propag
exampl
abpp
use
identifi
human
carboxylesteras
essenti
effici
hcv
propag
use
aid
character
previous
unknown
ubiquitin
proteas
catalyt
activ
site
tegument
protein
sever
herpesvirida
member
also
abpp
led
discoveri
new
promis
antivir
tetrahydroquinolin
oxocarbaz
cathepsin
l
inhibitor
abolish
sar
ebola
viru
entri
tabl
abpp
develop
determin
chang
catalyt
state
enzym
complex
proteom
ascrib
previous
unknown
enzymat
function
protein
abpp
use
activesitedirect
coval
probe
activitybas
probe
abp
consist
reactiv
group
link
report
tag
figur
often
abp
design
intent
exploit
conserv
mechanist
featur
target
enzym
superfamili
reaction
abp
activ
protein
target
usual
result
irrevers
coval
bond
figur
facilit
subsequ
analysi
report
tag
report
tag
gener
fluorophor
detect
visual
ingel
fluoresc
scan
biotin
purif
label
enzym
figur
abp
divid
least
three
differ
class
base
natur
warhead
reactiv
group
mechanismbas
abp
substratebas
abp
nondirect
abp
figur
tabl
mechanismbas
abp
also
known
direct
abp
contain
electrophil
reactiv
group
form
coval
bond
catalyt
amino
acid
residu
target
enzym
activ
site
figur
exampl
classwid
mechanismbas
abpp
probe
includ
fluorophosphon
phosphon
ester
modifi
fluoroglycosid
natur
product
like
wortmannin
microcystin
target
serin
hydrolas
glycosidas
kinas
threonin
phosphatas
famili
respect
although
mechanismbas
abp
effect
target
enzym
famili
known
coval
inhibitor
mani
enzym
class
use
conserv
activesit
nucleophil
electrophil
catalyz
enzymat
reaction
thu
form
coval
adduct
mechanismbas
suicid
inhibitor
broaden
number
enzym
class
address
abpp
nondirect
abp
contain
mild
electrophil
reactiv
group
develop
figur
exampl
nondirect
sulfon
ester
achloroacetamid
spiroepoxid
probe
use
success
label
differ
enzym
famili
variou
cellular
role
substratebas
abp
anoth
class
abp
exploit
versatil
chemic
scaffold
take
advantag
substrat
select
within
certain
famili
protein
usual
amino
acid
residu
peptid
figur
substratebas
scaffold
use
specif
region
target
probe
enzym
activ
site
figur
target
multitud
protein
candid
divers
rang
function
substrat
prefer
provid
better
understand
degre
virus
util
host
enzym
replic
infect
sever
abpp
studi
use
three
abp
class
recent
conduct
variou
viral
system
tabl
herein
highlight
focu
variou
applic
abpp
includ
identif
dysregul
enzym
function
result
viral
infect
assign
catalyt
function
previous
uncharacter
viral
protein
visual
alter
activ
proteom
situ
viral
diseas
progress
develop
new
antivir
therapeut
viral
diagnost
compar
abpp
figur
common
use
abpp
virolog
tabl
approach
origin
appli
toward
profil
applic
compar
differenti
activ
healthi
virusinfect
host
proteom
viral
protein
alter
host
proteom
good
candid
compar
abpp
analys
virus
contain
manag
number
protein
viral
infect
involv
coordin
hostviru
interact
eg
attach
cell
entri
uncoat
replic
express
virion
assembl
exit
sever
abp
influenza
hemagglutinintag
ubiquitin
haub
deriv
bromoethylamin
bond
catalyt
nucleophil
amino
acid
residu
activ
site
target
enzym
depict
fluorophosphon
abp
target
member
serin
hydrolas
superfamili
middl
panel
substratedirect
abp
depend
substratebas
scaffold
usual
amino
acid
residu
peptid
ubiquitin
act
specif
region
target
probe
catalyt
activ
site
enzym
follow
recognit
substratebas
scaffold
catalyt
nucleophil
enzym
enz
cleav
scissil
bond
proxim
substrat
scaffold
gener
anion
x
facilit
departur
fluorid
leav
group
f
gener
highli
reactiv
electrophil
quinolimin
methid
intermedi
react
nucleophil
residu
within
enzym
activ
site
bind
coval
probe
enzym
lower
panel
nondirect
abp
contain
mild
reactiv
group
electrophil
sulfon
ester
intermedi
reactiv
enough
modifi
catalyt
nucleophil
amino
acid
activ
state
low
enough
prevent
unspecif
label
nucleophil
residu
outsid
activ
site
depict
sulfon
ester
abp
target
sever
mechanist
distinct
class
enzym
detail
descript
differ
abp
class
histori
discoveri
warhead
reactiv
group
abp
label
mechan
found
elsewher
trend
biotechnolog
februari
vol
haub
vinylmethyl
ester
fluorophosphon
probe
success
use
compar
abpp
viral
infect
tabl
applic
abpp
toward
deubiquitin
enzym
famili
signific
import
unlik
ub
conjug
littl
known
remov
ub
ub
conjug
influenc
cellular
process
infect
haub
group
probe
tabl
substrat
specif
region
figur
target
probe
activ
site
ubiquitinspecif
proteas
usp
catalyt
cystein
residu
undergo
addit
vinylmethyl
ester
warhead
group
figur
creat
coval
bond
probe
figur
middl
panel
compar
activ
profil
abp
presenc
absenc
epsteinbarr
viru
ebv
human
papilloma
viru
hpv
infect
sever
deubiquitin
enzym
shown
upregul
well
ub
carboxyltermin
hydrolas
uch
one
identifi
target
upregul
late
viral
infect
correl
increas
cellular
growth
use
abpp
human
lymphoma
cervic
cancer
biopsi
measur
increas
activ
give
realist
understand
activ
link
malign
cellular
prolifer
rather
simpli
monitor
enzymat
activ
cell
line
anim
model
signific
effort
current
underway
character
differenti
activ
deubiquitin
enzym
downstream
target
elucid
molecular
detail
lead
ebvand
hpvinduc
malign
anoth
promis
target
compar
abpp
endogen
liver
enzym
identifi
fluorophosphon
mechanismbas
abp
tabl
figur
upper
panel
monitor
differenti
activ
serin
hydrolas
hcv
replic
infect
figur
activ
correl
hcv
abund
also
regul
hcv
replic
infect
cell
cultur
anim
model
figur
multifunct
enzym
modul
intracellular
neutral
lipid
eg
triglycerid
cholesterol
ester
biosynthesi
display
triacylglycerol
hydrolas
acylcoa
acyl
transferas
enzymat
activ
coher
antistok
raman
scatter
microscopi
also
use
demonstr
overexpress
give
rise
signific
increas
lipid
droplet
size
figur
also
involv
transport
neutral
lipid
intracellular
lipid
droplet
ld
subsequ
secret
verylow
densiti
lipoprotein
vldl
hcv
known
exploit
ld
vldl
cellular
pathway
replic
virion
assembl
bud
also
hcv
modul
host
metabol
pathway
increas
activ
alter
intracellular
environ
effici
replic
propag
figur
abpp
discoveri
role
increas
intracellular
lipid
content
hcv
propag
provid
better
understand
develop
liver
steatosi
ie
fatti
liver
phenotyp
outcom
found
mani
hcvinfect
patient
addit
present
possibl
host
target
develop
new
antivir
therapeut
although
mechanismbas
abpp
effect
analyz
enzym
known
coval
inhibitor
substratebas
nondirect
probe
also
appli
broaden
activitybas
profil
host
enzym
famili
could
involv
viral
replic
infect
tabl
appli
nondirect
sulfon
ester
varieti
substratebas
amino
acid
coupl
quinolimin
methid
abp
identifi
sever
differenti
activ
protein
hcv
replic
encompass
mani
enzym
famili
broader
specif
substratebas
abp
like
attribut
singl
amino
acid
composit
probe
electrophil
properti
quinolimin
methid
intermedi
specif
probe
would
improv
substitut
singl
amino
acid
dior
oligopeptid
substrat
shown
tripeptid
epoxid
hexapeptid
diphenylphosphon
abp
discuss
identifi
abpp
target
heat
shock
protein
nuclear
distribut
gene
c
homolog
chaperonin
contain
protein
disulfid
isomeras
cathepsin
isochorismatas
domain
contain
observ
alter
activ
hcv
replic
virtual
unchang
abund
differenti
activ
probabl
attribut
posttransl
modif
cofactorinhibitor
associ
would
undetect
convent
proteom
techniqu
identif
nondirect
abpp
target
suggest
combinatori
mechanismbas
abpp
method
acceler
discoveri
protein
activ
associ
pathogen
state
viral
infect
situin
vivo
viral
abpp
applic
click
chemistri
earli
version
abp
design
bulki
report
group
ie
fluorophor
biotin
limit
uptak
distribut
cell
tissu
henc
initi
abpp
protocol
restrict
usag
abp
vitro
experi
homogen
cell
tissu
result
loss
cellular
compartment
alter
biodistribut
cofactor
inhibitor
bind
partner
essenti
enzymat
regul
probabl
repres
true
function
state
target
enzym
provid
physiolog
relev
enzymat
profil
enzym
need
assess
within
context
nativ
subcellular
environ
accomplish
vivo
abp
contain
small
bioorthogon
report
group
typic
termin
alkyn
b
azid
n
figur
develop
small
size
bioorthogon
report
group
greatli
improv
abp
cell
permeabl
distribut
cell
situ
vivo
proteom
label
visual
isol
enzym
bound
alkyn
abp
alkynelabel
proteom
subsequ
react
n
contain
report
tag
via
coppercatalyz
azidealkyn
cycloaddit
commonli
refer
click
chemistri
reaction
figur
situ
abpp
label
techniqu
shown
group
use
nondirect
sulfon
ester
alkyn
abp
hcv
replic
deliv
signific
label
dispar
vitro
situ
abpp
number
protein
candid
label
situ
abp
doubl
compar
vitro
label
cell
homogen
demonstr
catalyt
activ
greatli
influenc
structur
integr
enzym
nativ
subcellular
environ
illustr
key
advantag
situ
vivo
abpp
rel
larg
dna
genom
herp
virus
openread
frame
made
popular
viru
group
character
abpp
novel
catalyt
function
express
viral
gene
product
import
advanc
recent
made
character
multifunct
activ
highli
variabl
tegument
protein
sever
herpesvirida
member
use
haub
vinylmethyl
ester
abp
tabl
despit
share
sequenc
similar
herpesvirida
member
abpp
abl
identifi
import
conserv
deubiquitin
enzymat
activ
ntermin
segment
murin
human
cytomegalovirus
ebv
herp
simplex
viru
chicken
marek
diseas
viru
mdv
murin
gammaherpesviru
one
studi
use
mutagenesi
haub
vinylmethyl
ester
abp
led
identif
catalyt
activ
cystein
mdv
larg
tegument
protein
link
oncogen
potenti
mdv
chicken
deubiquitin
activ
herpesvirida
tegument
protein
believ
implic
viral
gene
transcript
cell
cycl
regul
virion
bud
also
tumor
develop
despit
immens
complex
herp
genom
highli
conserv
deubiquitin
catalyt
site
tegument
protein
among
alpha
beta
gammaherpesvirus
great
potenti
antivir
therapeut
develop
similarli
anoth
group
use
hexapeptid
diphenylphosphon
abp
studi
activ
poorli
understood
kaposisarcomaassoci
herpesviru
human
herpesviru
proteas
tabl
character
activ
site
proteas
abpp
catalyt
activ
shown
depend
quaternari
structur
result
dimer
activ
site
monom
catalyt
independ
discov
link
proteas
quaternari
structur
catalyt
activ
offer
altern
inhibit
strategi
could
use
hexapeptid
diphenylphosphon
abp
develop
screen
substoichiometr
inhibitor
could
destabil
dimer
interfac
competit
abpp
antivir
inhibitor
screen
given
virus
requir
host
propag
vulner
inhibit
cellular
pathway
convent
antivir
drug
focus
select
target
viral
gene
product
minim
side
effect
experienc
patient
limit
number
viral
target
rapid
emerg
drugresist
viral
mutat
necessit
search
host
cell
target
altern
antivir
therapeut
develop
hostviru
interact
becom
appar
abpp
use
screen
inhibitor
novel
host
target
competit
assay
assay
rel
potent
inhibitor
identifi
abil
block
access
abp
enzym
activ
site
figur
competit
abpp
recent
appli
screen
test
antivir
drug
sar
coronaviru
cov
ebola
pseudotyp
viru
biotin
tripeptid
epoxid
abp
alkyl
linkertyrleuepoxid
tabl
use
determin
efficaci
novel
tetrahydroquinolin
oxocarbaz
cid
inhibitor
host
human
cell
cathepsin
l
target
endosom
cathepsin
l
appeal
target
antivir
develop
mediat
viral
entri
trigger
fusion
plasma
membran
endosom
via
proteolysi
abp
reveal
tetrahydroquinolin
oxocarbaz
inhibitor
cell
permeabl
reduc
activ
cathepsin
l
find
demonstr
potenti
role
abp
identifi
novel
inhibitor
oxocarbaz
inhibitor
cid
subnanomolar
slowbind
revers
inhibitor
human
cathepsin
l
prevent
sar
ebola
viru
entri
human
cell
applic
abp
could
explor
mechan
viral
entri
screen
potent
inhibitor
similarli
abp
target
extracellular
membran
protein
use
viral
diagnost
develop
substratebas
sialicacidcontain
abp
probe
incorpor
orthodifluoromethylphenyl
trap
moieti
tabl
immobil
surfac
micropl
well
success
captur
influenza
virion
particl
neuraminidas
surfac
glycoprotein
immobil
influenza
virion
particl
function
surfac
via
abp
potenti
acceler
simultan
screen
hundr
antivir
antibodi
drug
furthermor
abp
substratebas
probe
contain
sialic
acid
orthodifluoromethylphenyl
trap
moieti
could
also
influenc
viral
diagnost
gener
uniqu
activ
profil
dozen
viral
speci
strain
match
unknown
specimen
identif
combin
live
cell
imag
abpp
give
research
abil
monitor
rapidli
chang
subcellular
enzymat
activ
viral
pathogenesi
real
time
figur
although
base
click
chemistri
figur
sulforhodamin
valylalanylaspart
acid
fluoromethyl
keton
srvadfmk
poli
caspas
abp
tabl
cellmembraneperm
make
suitabl
situ
vivo
abpp
situ
applic
srvadfmk
norovirusinfect
mous
macrophag
cell
shown
activ
caspas
cystein
proteas
occur
within
h
viral
infect
vitro
abpp
character
studi
identifi
cathepsin
b
novel
host
enzym
increas
activ
earli
viral
infect
impli
murin
noroviru
could
take
advantag
cathepsinbinduc
apoptosi
transfer
fragment
membran
bodi
neighbor
cell
gelbas
abpp
approach
robust
enough
identifi
abundantli
express
protein
lack
abil
identifi
lowabund
target
protein
recent
abpp
gelfre
approach
use
liquid
chromatographi
enrich
identifi
abpplabel
protein
target
presenc
highli
abund
unlabel
host
protein
contamin
abppmudpit
highthroughput
character
label
protein
combin
simultan
identif
probelabel
site
topabpp
could
speed
activ
site
character
newli
identifi
antivir
target
therapeut
inhibitor
screen
modern
virolog
antivir
drug
discoveri
thu
expect
progress
enhanc
new
research
involv
viral
abpp
activitybas
technolog
current
target
dozen
class
enzym
coval
inhibitor
discov
repertoir
address
enzym
famili
increas
cover
larger
portion
activ
proteom
abpp
valuabl
techniqu
provid
uniqu
inform
enzymat
activ
proteom
complement
largescal
profil
method
abundancebas
proteom
silac
microarray
system
biolog
approach
futur
challeng
applic
abpp
virolog
determin
myriad
host
enzym
essenti
viru
infect
newli
identifi
abpp
candid
repres
novel
target
develop
viral
diagnost
antivir
therapeut
